PD-Rx Pharmaceuticals Famotidine Recall: FDA Class II

Why it was recalled

Failed Tablet/Capsule Specification: out of specification for tablet weight.

Product description

Famotidine USP 20 mg, 30 tablets bottle, Rx, PKG By; PD Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127 --- NDC 55289-765-30

Lot numbers, UPCs & expiration codes

Lot: A17F55 Exp. 06/30/2018

Where it was sold

Nationwide

What to do if you have this product

Compare the lot number and expiration date on your package with the codes above.
Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
If you have symptoms you think are related, contact your doctor. In an emergency call 911.
Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number: D-1057-2017
Classification: Class II
Status: Terminated
Recall initiated: Jul 28, 2017
FDA report date: Aug 9, 2017
Quantity: 100 bottles
Recall type: Voluntary: Firm initiated
Recalling firm: PD-Rx Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-1057-2017, exactly as published.

Show all FDA fields

City: Oklahoma City
State: OK
Status: Terminated
Country: United States
Event ID: 77847
Address: 727 N Ann Arbor Ave
Code information: Lot: A17F55 Exp. 06/30/2018
Postal code: 73127-5822
Report date: Aug 9, 2017
Product type: Drugs
Recall number: D-1057-2017
Classification: Class II
Recalling firm: PD-Rx Pharmaceuticals, Inc.
Product quantity: 100 bottles
Termination date: Dec 6, 2017
Reason for recall: Failed Tablet/Capsule Specification: out of specification for tablet weight.
Voluntary / mandated: Voluntary: Firm initiated
Product description: Famotidine USP 20 mg, 30 tablets bottle, Rx, PKG By; PD Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127 --- NDC 55289-765-30
Distribution pattern: Nationwide
Recall initiation date: Jul 28, 2017
Initial firm notification: E-Mail
Center classification date: Aug 3, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1057-2017, published Aug 9, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: Oct 2, 2026. Content last changed: Oct 2, 2026.

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

PD-Rx Pharmaceuticals Famotidine 20 mg Recall

Summary